Panion & BF Biotech Inc.(TW:1760)
NT$47.70-1.65 (-3.34%)
TW:1760
Panion & BF Biotech Inc. Revenue
NT$47.70
At close:-1.65 (-3.34%)
Panion & BF Biotech Inc. (1760) Revenue
Panion & BF Biotech Inc. Revenue
Panion & BF Biotech Inc. had a revenue of 511.84M in the quarter ending Jun 30, 2026, with -1.44%. This bring the company's revenue in the last twelve months to 2.11B, Increased 0.38%. In the fiscal year ending Dec 31, 2025, Panion & BF Biotech Inc. had annual revenue of 2.06B with 1.66% growth.
- Revenue (ttm)
- 2.11B
- Revenue Growth
- 1.43%
- P/S Ratio
- 2.05
- Revenue/Employee
- TWD 6,428,012
- Employees
- 321
- Market Cap
- TWD 4.23B
Revenue Chart
Panion & BF Biotech Inc. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.06B | 33.75M | 1.66% |
| Dec 31, 2024 | 2.03B | 147.77M | 7.85% |
| Dec 31, 2023 | 1.88B | -516.77M | -21.54% |
| Dec 31, 2022 | 2.40B | 497.44M | 26.16% |
| Dec 31, 2021 | 1.90B | 332.57M | 21.20% |
| Dec 31, 2020 | 1.57B | -5.31M | -0.34% |
| Dec 31, 2019 | 1.57B | 165.20M | 11.73% |
| Dec 31, 2018 | 1.41B | 196.26M | 16.19% |
| Dec 31, 2017 | 1.21B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.